Lannett To Report Fiscal 2021 Fourth-quarter, Full-year Financial Results, Host Conference Call On Wednesday, August 25PRNewsWire • 08/18/21
LANNETT expands respiratory pipeline, signs exclusive distribution agreement for generic SPIRIVA® handihaler®PRNewsWire • 07/29/21
Lannett Announces FDA Acceptance, As A Priority Original ANDA, Of The Generic Advair Diskus® FilingPRNewsWire • 06/01/21
Organon Set to Join S&P 500; HollyFrontier to Join S&P MidCap 400; Service Properties Trust to Join S&P SmallCap 600PRNewsWire • 05/27/21
Lannett Company, Inc. (LCI) CEO Tim Crew on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/06/21
Lannett To Report Fiscal 2021 Third-Quarter Financial Results, Host Conference Call On Wednesday, May 5PRNewsWire • 04/28/21
Lannett Announces Closing Of $350 Million Senior Secured Notes And $190 Million Second Lien Senior Secured Loan FacilityPRNewsWire • 04/22/21
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lannett Company, Inc. - LCINewsfile Corp • 03/22/21
Lannett plans to file experimental insulin product with FDA sometime this yearMarket Watch • 03/10/21
Lannett Company, Inc. (LCI) CEO Tim Crew on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/04/21